Global Vagal Nerve Stimulation (VNS) Market Forecast till 2027


Posted December 20, 2021 by sonikashukla98

The Vagal Nerve Stimulation (VNS) market is anticipated to surpass USD 1,076.83 million by 2027 with a significant CAGR of 10.30%.
 
Bharat Book Bureau Provides the Trending Market Research Report on “Global Vagal Nerve Stimulation (VNS) Market: Information by Products (Implantable VNS Devices, External VNS Devices), By Application (Depression, Epilepsy, Others), By End User (Hospitals, Ambulatory Surgical Centers), and Region(North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027” under Life Sciences Market Research Reports Category. Our report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

The Vagal Nerve Stimulation (VNS) market is anticipated to surpass USD 1,076.83 million by 2027 with a significant CAGR of 10.30%. Vagus nerve stimulation includes the utilization of a gadget to invigorate the vagus nerve with electrical driving forces. An implantable vagus nerve trigger is presently FDA-endorsed to treat epilepsy and melancholy. The outside Vagal Nerve Stimulation (VNS) gadgets depend totally on electrical signs that can be going through the skin and muscles of the neck without influencing the tissue it is going through. This method should be sufficiently exact to manage and get to explicit action of the nerve. Development in innovation and the presentation of new outside VNS gadgets are relied upon to fuel the development of the vagal nerve trigger market.

The worldwide Vagal Nerve Stimulation (VNS) market is fundamentally determined by the expanding pervasiveness of neurological problems and rising speculation of biotechnology and drug ventures in R&D. In any case, factors, for example, the greater expense of the vagal nerve stimulation treatment strategy are relied upon to confine the market's development during the estimate time frame. Besides, the expanding vital consolidations and acquisitions will set out open doors for market players. However, the higher cost of vagal nerve stimulation treatment procedure is set to hamper the global market growth during the review period.

Segment Overview

The global Vagal Nerve Stimulation (VNS) market has been classified into products, applications, and end-user.

By-Products type the global market is divided into Implantable VNS Devices and External VNS Devices.

Based on Application the market is categorized into depression, epilepsy, and others.

In terms of the end-user segment, the global market is classified into hospitals, ambulatory surgical centers, and others.

Regional Analysis

The global vagal nerve stimulation (VNS) market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

North America is expected to command the global vagal stimulation (VNS) market with a healthy CAGR of 9.87% during the review period. the regional market is attributed to the advanced technology, rising prevalence of neurological disorders, increasing healthcare expenditure, and supportive government support for research & development. Europe contributes the second position in the global vagal nerve stimulation market owing to the increasing government support and funding for research & development.

The Asia-Pacific vagal nerve stimulation market is expected to register a significant CAGR of 10.69% during the study period. The regional market is attributed to the existence of rapidly developing healthcare technology, a large patient population, and increased healthcare expenditure. The Rest of the World's vagal nerve stimulation market is categorized into two major regions, namely the Middle East & Africa and Latin America.

Key Competitors

The major players of the global vagal nerve stimulation market are LivaNova, PLC (UK), ReShape Lifesciences Inc (US), ElectroCore Medical LLC (US), Boston Scientific Corporation (US), NeuroMetrix, Inc. (US), ImThera Medical, Inc. (US), Inspire Medical Systems, Inc (US), Parasym Ltd (UK), and Innovative Health Solutions, Inc. (the US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Browse our full report with Table of Content :
https://www.bharatbook.com/report/1045907/global-vagal-nerve-stimulation-vns-market-information-by-products-implantable-vns-devices-external-vns-devices-by-application-depression-epilepsy-others-by-end-user-hospitals-ambulatory-surgical-centers-and-regionn

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By sonika
Phone 02227810772
Business Address 808, Real Tech Park, Sector - 30A, Vashi, Navi Mumbai.
Country India
Categories Health
Tags life sciences market research report , vagal nerve stimulation vns industry market report , vagal nerve stimulation vns industry market research report
Last Updated December 20, 2021